Literature DB >> 14600648

Hepatocellular carcinoma: a clinical update.

Fernando Pons-Renedo1, Josep M Llovet.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14600648

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


× No keyword cloud information.
  5 in total

1.  Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.

Authors:  Jingmei Ye; Jiani Wang; Li Tan; Shaojiang Yang; Lihua Xu; Xiaohong Wu; Huaifu Deng; Huo Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  Sorafenib for treatment of hepatocellular carcinoma: a systematic review.

Authors:  Bingru Xie; David H Wang; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

3.  Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.

Authors:  Suchithra Menon; Jessica L Yecies; Hui H Zhang; Jessica J Howell; Justin Nicholatos; Eylul Harputlugil; Roderick T Bronson; David J Kwiatkowski; Brendan D Manning
Journal:  Sci Signal       Date:  2012-03-27       Impact factor: 8.192

4.  Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.

Authors:  Kishore Polireddy; Hemantkumar Chavan; Bashar A Abdulkarim; Partha Krishnamurthy
Journal:  Mol Oncol       Date:  2011-07-28       Impact factor: 6.603

5.  Targeted therapy in hepatocellular carcinoma.

Authors:  Clarinda W L Chua; Su Pin Choo
Journal:  Int J Hepatol       Date:  2011-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.